Medical disclaimer

Sermorelin Co publishes educational information about sermorelin (GRF 1-29): its history, mechanism, evidence, and regulatory status. Nothing on this site is medical advice, a diagnosis, or a recommendation to use sermorelin or any other compound. Reading this site does not create a clinician relationship of any kind.

Sermorelin was once FDA-approved as Geref, which was discontinued for commercial reasons. FDA determined it was not withdrawn for safety or effectiveness. No FDA-approved sermorelin product is on the market today; current versions are compounded and not FDA-reviewed. Decisions about compounded sermorelin belong with a licensed prescriber and pharmacist who know your history.

Dosing, monitoring (including IGF-1 labs), interactions, and whether sermorelin is appropriate for you at all are individual clinical questions. Consult a licensed clinician before starting, stopping, or changing any hormone-related therapy. If you have or have had cancer, are pregnant or breastfeeding, or have pituitary disease, that conversation is non-optional.

This site is not for emergencies; if you believe you are experiencing one, call your local emergency number. If you believe something on this sermorelin site is factually wrong, our editorial standards page explains how corrections work and how to reach us.